✦ LIBER ✦

α4β2-Nicotinic Receptor Binding with 5-IA in Alzheimer’s Disease: Methods of Scan Analysis

✍ Scribed by Emma Terrière; Mike Sharman; Claire Donaghey; Lucie Herrmann; Jane Lonie; Marion Strachan; Nadine Dougall; Jonathan Best; Klaus P. Ebmeier; Sally Pimlott; Jim Patterson; David Wyper

Publisher: Springer
Year: 2007
Tongue: English
Weight: 274 KB
Volume: 33
Category: Article
ISSN: 0364-3190
DOI: 10.1007/s11064-007-9517-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decreased cerebral α4β2* nicotinic acety

Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography

✍ Kai Kendziorra; Henrike Wolf; Philipp Mael Meyer; Henryk Barthel; Swen Hesse; Ge 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 485 KB

Correlation of nicotinic receptor bindin

Correlation of nicotinic receptor binding with clinical and neuropathological changes in Alzheimer's disease and dementia with Lewy bodies

✍ M. N. Sabbagh; R. T. Reid; L. A. Hansen; M. Alford; L. J. Thal 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 64 KB

Galantamine-induced improvements in cogn

Galantamine-induced improvements in cognitive function are not related to alterations in α4β2nicotinic receptors in early Alzheimer’s disease as measured in vivo by 2-[18F]Fluoro-A-85380 PET

✍ J. R. Ellis; P. J. Nathan; V. L. Villemagne; R. S. Mulligan; T. Saunder; K. Youn 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 286 KB

Discovery of (S)-2-((S)-2-(3,5-Difluorop

Discovery of (S)-2-((S)-2-(3,5-Difluorophenyl)-2-hydroxyacetamido)-N-( (S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d] [1,2]diazepin-5-yl)propanamide (BMS-433796): A γ-Secretase Inhibitor with Aβ Lowering Activity in a Transgenic Mouse Model of Alzheimer′s Disease.

✍ C. V. C. Prasad; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views